Reproductive Biomedicine Online, published by Elsevier, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Developmental Biology, Obstetrics and Gynecology, and Reproductive Medicine. With an impressive Impact Factor and a Q1 ranking in its respective disciplines as of 2023, this journal provides a platform for innovative research and comprehensive reviews that contribute to advancements in reproductive healthcare. The journal boasts rigorous Scopus rankings, placing it within the top tiers of its categories, which underscores its significance in shaping contemporary biomedical inquiry. Although not open access, it remains widely accessible through institutional subscriptions, making its wealth of knowledge available to researchers, clinicians, and students alike. Since its inception in 2000, Reproductive Biomedicine Online has been committed to fostering a deeper understanding of reproductive processes and biomedicine, ensuring that its content remains relevant and impactful in addressing challenges in reproductive health, thereby championing exceptional scientific discourse.

Human Fertility, published by Taylor & Francis Ltd, is a key academic journal that serves the dynamic fields of medicine, obstetrics and gynecology, and reproductive medicine. Established in 1998 and with converged content extending to 2024, the journal holds a notable Q2 ranking in its respective categories, highlighting its influence and scholarly contributions to current research and practice. With an ISSN of 1464-7273 and an E-ISSN of 1742-8149, it rigorously disseminates studies, reviews, and advancements in human fertility, particularly emphasizing evidence-based practices and innovative techniques. Despite its traditional subscription model, the journal remains vital for researchers, healthcare professionals, and students seeking to foster advancements in reproductive health. Its articles are pivotal in addressing the multifaceted challenges faced in reproductive health and guiding future research trajectories.

Reproduction, Fertility and Development, published by CSIRO Publishing, is a prestigious journal that has been at the forefront of research in the fields of reproductive science, developmental biology, and related disciplines since its inception in 1989. With an ISSN of 1031-3613 and an E-ISSN of 1448-5990, this journal serves as a vital platform for disseminating innovative findings and methodologies that advance our understanding of reproductive processes and development in a variety of organisms. The journal is indexed in prominent databases, exhibiting a solid standing with a Q3 quartile ranking in both Animal Science and Zoology and Biotechnology, and covering 2023 rankings in multiple related categories. Operating from Australia, Reproduction, Fertility and Development embraces a commitment to enriching scholarly communication and fostering collaborative research efforts. Its focus on high-quality, peer-reviewed articles makes it an essential resource for researchers, professionals, and students seeking to stay abreast of the latest advancements and pivotal discussions in reproductive medicine and developmental biology.

Fertility and Sterility is a prestigious peer-reviewed journal dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier Science Inc, this journal has been a cornerstone of scientific discourse since its inception in 1950 and is set to continue its influential coverage of cutting-edge research until 2024. Boasting an impressive impact factor, Fertility and Sterility is ranked among the top-tier journals in its category, holding Q1 status in both Obstetrics and Gynecology and Reproductive Medicine. With Scopus rankings placing it in the 97th and 96th percentiles respectively, the publication serves as a vital resource for researchers, clinicians, and students who seek to advance their understanding of fertility issues and reproductive health. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and innovative solutions to the complex challenges in reproduction, empowering professionals and scholars to make meaningful contributions in their fields.

BIOLOGY OF REPRODUCTION is a premier journal published by Oxford University Press Inc, dedicated to advancing research in the fields of reproductive biology, cell biology, and reproductive medicine. With an impressive impact factor and a strong ranking as Q1 in reproductive medicine and miscellaneous medicine, as well as Q2 in cell biology, this journal offers a vital platform for disseminating innovative findings and pivotal studies that shape our understanding of reproductive processes. Since its inception in 1969, BIOLOGY OF REPRODUCTION has become a key resource for scientists, clinicians, and students alike, providing insights that drive the future of reproductive health and research. Although not an open-access publication, it remains a respected authority, reflecting a commitment to high-quality peer-reviewed articles. The journal's comprehensive scope includes molecular and cellular aspects of reproduction, reproductive health, and associated technologies, making it indispensable for professionals looking to stay at the forefront of breakthroughs within the field.

REPRODUCTION, published by BIOSCIENTIFICA LTD, stands at the forefront of research in the fields of reproductive and developmental biology. With a focus on advancing our understanding of reproductive health and mechanisms, the journal has garnered an impressive reputation, consistently ranking in the first quartile for key categories including Embryology, Endocrinology, Obstetrics and Gynecology, and Reproductive Medicine in 2023. Notably, it holds an esteemed position in the Scopus rankings, with high percentiles that reflect its significant impact in the scientific community. The journal is committed to open access, promoting the broad dissemination of high-quality research to facilitate innovative discoveries and interdisciplinary collaboration. Situated in the United Kingdom, REPRODUCTION serves as a vital resource for researchers, professionals, and students eager to contribute to the evolving landscape of reproductive sciences and related fields.

HUMAN REPRODUCTION UPDATE, published by Oxford University Press, stands as a leading journal in the fields of Obstetrics and Gynecology and Reproductive Medicine. With an impressive Q1 ranking in both categories according to the 2023 category quartiles and a significant Scopus rank, it is recognized as one of the top journals globally in these disciplines, catering to the most relevant and cutting-edge research. The journal has been a crucial platform for disseminating vital findings and reviews from 1995 to 2024, contributing to advancements in human reproductive health. With its focus on publishing high-quality, peer-reviewed articles, it serves as an essential resource for researchers, healthcare professionals, and students seeking the latest insights and developments in reproductive science. As the journal aims to foster informed discussions and encourage further research, it remains committed to shaping the future of reproductive health and medicine.

ZYGOTE is a prominent academic journal published by Cambridge University Press, focusing on the fields of Cell Biology and Developmental Biology. Established in 1993, this journal serves as a platform for high-quality research that advances our understanding of the complex processes that underlie cellular and developmental mechanisms. While currently classified in the Q4 quartile for both fields, ZYGOTE provides valuable insights and contributions from early-stage research to established studies, making it a noteworthy resource for researchers and professionals seeking to explore innovative developments in biology. Although it does not offer open access, the journal maintains rigorous peer-review standards to ensure the integrity and relevance of the published work. With its ongoing commitment to disseminating knowledge, ZYGOTE plays a significant role in the scientific community, fostering collaboration and inspiration among students, researchers, and professionals alike.

Reproductive and Developmental Medicine is a pioneering open-access journal dedicated to advancing knowledge in the fields of reproductive medicine and developmental biology. Published by LIPPINCOTT WILLIAMS & WILKINS, the journal serves as a platform for researchers, clinicians, and graduate students alike, fostering collaboration and dissemination of innovative research findings. With an ISSN of 2096-2924 and E-ISSN 2589-8728, it has established a significant presence in the academic community since its inception in 2017. The journal is indexed in Scopus and achieved a category quartile ranking of Q3 in Obstetrics and Gynecology and Q4 in Reproductive Medicine as of 2023, highlighting its importance as a resource for cutting-edge studies and reviews in these vital areas. The journal's open-access model ensures that research is readily available to scholars and practitioners worldwide, thus enhancing the global discourse in reproductive health and development. This makes Reproductive and Developmental Medicine an invaluable resource for those dedicated to improving outcomes in obstetrics, gynecology, and reproductive health.

Middle East Fertility Society Journal is a premier open-access publication established in 1996 that caters to the fields of Obstetrics and Gynecology as well as Reproductive Medicine. Published by SPRINGER in Egypt, this journal has made significant strides in disseminating high-quality research and advancements in reproductive health, achieving a 2023 Scopus rank of #102 in Obstetrics and Gynecology and #47 in Reproductive Medicine, placing it in the 51st and 48th percentiles respectively. With an aim to foster collaboration and innovation in the fertility sector, it welcomes researchers and practitioners to share their findings and insights, contributing to the global discourse on reproductive issues. As an open-access journal since 2010, it ensures that the latest research is readily available to a broad audience, enhancing accessibility and knowledge transfer in the vital area of reproductive health.